Professor Charles D Pusey

Publications


Journals

  • Shalchi Z; Lightman SL; Pusey CD; Taylor SRJ. (24 Feb 2012). A sore red eye with systemic involvement. BRITISH MEDICAL JOURNAL. 344. Author weblink DOI.
  • Mcadoo SP; Pusey CD. (1 Dec 2011). Acute renal failure in diabetes: looking beyond diabetic retinopathy. CLINICAL MEDICINE. 11:629-629. Author weblink.
  • Pusey CD; Levy JB. (2012). Plasmapheresis in immunologic renal disease. Blood Purif. 33:190-198. DOI.
  • Sharp PE; Martin-Ramirez J; Boross P; Mangsbo SM; Reynolds J; Moss J; Pusey CD; Cook HT; et alTarzi RM; Verbeek JS. (Feb 2012). Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alone. Mol Immunol. 50:49-56. DOI.
  • Page TH; D'Souza Z; Nakanishi S; Serikawa T; Pusey CD; Aitman TJ; Cook HT; Behmoaras J. (17 Feb 2012). Role of novel rat-specific Fc receptor in macrophage activation associated with crescentic glomerulonephritis. J Biol Chem. 287:5710-5719. DOI.
  • Reynolds J; Sando GS; Marsh OB; Salama AD; Evans DJ; Cook HT; Pusey CD. (Apr 2012). Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis. Nephrol Dial Transplant. 27:1343-1350. DOI.
  • Morris H; Morgan MD; Wood AM; Smith SW; Ekeowa UI; Herrmann K; Holle JU; Guillevin L; et alLomas DA; Perez J; Pusey CD; Salama AD; Stockley R; Wieczorek S; McKnight AJ; Maxwell AP; Miranda E; Williams J; Savage CO; Harper L. (1 Oct 2011). ANCA-associated vasculitis is linked to carriage of the Z allele of alpha(1) antitrypsin and its polymers. ANNALS OF THE RHEUMATIC DISEASES. 70:1851-1856. Author weblink DOI.
  • Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR. (Dec 2011). Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective. Ophthalmology. 118:2498-2503. DOI.
  • Tarzi RM; Sharp PE; McDaid JP; Fossati-Jimack L; Herbert PE; Pusey CD; Cook HT; Warrens AN. (Jan 2012). Mice with defective Fas ligand are protected from crescentic glomerulonephritis. Kidney Int. 81:170-178. DOI.
  • Arulkumaran N; Periselneris N; Gaskin G; Strickland N; Ind PW; Pusey CD; Salama AD. (Nov 2011). Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford). 50:2035-2043. DOI.
  • Arulkumaran N; Jawad S; Smith SW; Harper L; Brogan P; Pusey CD; Salama AD. (19 Jun 2011). Long- term outcome of paediatric patients with ANCA vasculitis. PEDIATRIC RHEUMATOLOGY. 9. DOI.
  • Fragiadaki M; Witherden AS; Kaneko T; Sonnylal S; Pusey CD; Bou-Gharios G; Mason RM. (Sep 2011). Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. Matrix Biol. 30:396-403. DOI.
  • Tarzi RM; Cook HT; Pusey CD. (Jul 2011). Crescentic glomerulonephritis: new aspects of pathogenesis. Semin Nephrol. 31:361-368. DOI.
  • Kim MJ; Frankel AH; Donaldson M; Darch SJ; Pusey CD; Hill PD; Mayr M; Tam FW. (Oct 2011). Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int. 80:851-860. DOI.
  • Arulkumaran N; Jawad S; Smith SW; Harper L; Brogan P; Pusey CD; Salama AD. (2011). Long- term outcome of paediatric patients with ANCA vasculitis. Pediatr Rheumatol Online J. 9:12. DOI.
  • Guerry MJ; Brogan P; Bruce IN; D'Cruz DP; Harper L; Luqmani R; Pusey CD; Salama AD; et alScott DG; Savage CO; Watts RA; Jayne DR. (Apr 2012). Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford). 51:634-643. DOI.
  • Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD. (May 2011). Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis. Nephrology (Carlton). 16:410-416. DOI.
  • Walsh M; Catapano F; Szpirt W; Thorlund K; Bruchfeld A; Guillevin L; Haubitz M; Merkel PA; et alPeh CA; Pusey C; Jayne D. (1 Apr 2011). Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis. AMERICAN JOURNAL OF KIDNEY DISEASES. 57:566-574. Author weblink DOI.
  • Bonomini M; Zammit V; Pusey CD; De Vecchi A; Arduini A. (1 Mar 2011). Pharmacological use of L-carnitine in uremic anemia: Has its full potential been exploited?. PHARMACOLOGICAL RESEARCH. 63:157-164. Author weblink DOI.
  • Mansfield N; Hamour S; Habib AM; Tarzi R; Levy J; Griffith M; Cairns T; Cook HT; et alPusey CD; Salama AD. (Oct 2011). Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis. Nephrol Dial Transplant. 26:3280-3286. DOI.
  • Tarzi RM; Pusey CD. (May 2011). Vasculitis: Risks and rewards of treating elderly patients with vasculitis. Nat Rev Nephrol. 7:253-255. DOI.
  • Flossmann O; Berden A; de Groot K; Hagen C; Harper L; Heijl C; Hoglund P; Jayne D; et alLuqmani R; Mahr A; Mukhtyar C; Pusey C; Rasmussen N; Stegeman C; Walsh M; Westman K. (1 Mar 2011). Long-term patient survival in ANCA-associated vasculitis. ANNALS OF THE RHEUMATIC DISEASES. 70:488-494. DOI.
  • Berden AE; Ferrario F; Hagen EC; Jayne DR; Jennette JC; Joh K; Neumann I; Noel L-H; et alPusey CD; Waldherr R; Bruijn JA; Bajema IM. (1 Oct 2010). Histopathologic Classification of ANCA-Associated Glomerulonephritis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 21:1628-1636. Author weblink DOI.
  • Gale DP; de Jorge EG; Cook HT; Martinez-Barricarte R; Hadjisavvas A; McLean AG; Pusey CD; Pierides A; et alKyriacou K; Athanasiou Y; Voskarides K; Deltas C; Palmer A; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Maxwell PH; Pickering MC. (4 Sep 2010). Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. LANCET. 376:794-801. DOI.
  • Stangou M; Bhangal G; Lai PC; Smith J; Keith JC; Boyle JJ; Pusey CD; Cook T; et alTam FW. (Jan 2011). Effect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto rats. J Nephrol. 24:106-111.
  • Nogueira E; Hamour S; Sawant D; Henderson S; Mansfield N; Chavele K-M; Pusey CD; Salama AD. (1 Jul 2010). Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 25:2209-2217. Author weblink DOI.
  • Hamour S; Salama AD; Pusey CD. (2010). Management of ANCA-associated vasculitis: Current trends and future prospects. Ther Clin Risk Manag. 6:253-264.
  • Behmoaras J; Smith J; D'Souza Z; Bhangal G; Chawanasuntoropoj R; Tam FW; Pusey CD; Aitman TJ; et alCook HT. (Jul 2010). Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis. J Am Soc Nephrol. 21:1136-1144. DOI.
  • Chavele KM; Martinez-Pomares L; Domin J; Pemberton S; Haslam SM; Dell A; Cook HT; Pusey CD; et alGordon S; Salama AD. (May 2010). Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice. J Clin Invest. 120:1469-1478. DOI.
  • Pusey C; Dash C; Garrett M; Gascoigne E; Gesinde M; Gillanders K; Wallington T. (1 Aug 2010). Experience of using human albumin solution 4.5% in 1195 therapeutic plasma exchange procedures. Transfus Med. 20:244-249. DOI.
  • Chavele KM; Shukla D; Keteepe-Arachi T; Seidel JA; Fuchs D; Pusey CD; Salama AD. (May 2010). Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation. Arthritis Rheum. 62:1539-1548. DOI.
  • Annear NMP; Cook HT; Atkins M; Pusey CD; Salama AD. (1 Jan 2010). Non-hepatitis virus associated mixed essential cryoglobulinemia. KIDNEY INTERNATIONAL. 77:161-164. Author weblink DOI.
  • Smith J; McDaid JP; Bhangal G; Chawanasuntorapoj R; Masuda ES; Cook HT; Pusey CD; Tam FW. (Feb 2010). A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis. J Am Soc Nephrol. 21:231-236. DOI.
  • Kamesh L; Heward JM; Williams JM; Gough SCL; Chavele K-M; Salama A; Pusey C; Savage COS; et alHarper L. (1 Dec 2009). CT60 and+49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. RHEUMATOLOGY. 48:1502-1505. Author weblink DOI.
  • Behmoaras J; Cook HT; Pusey CD. (1 Oct 2009). Kallikreins: unravelling the genetics of autoimmune glomerulonephritis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 24:2987-2989. Author weblink DOI.
  • Chavele K-M; Martinez-Pomares L; Gordon S; Cook T; Pusey C; Salama A. (1 Jun 2009). Circulating mannose receptor is elevated in acute ANCA-associated vasculitis and contributes in the development of experimental glomerulonephritis. APMIS. 117:154-154. Author weblink.
  • Flossmann O; Berden A; De Groot K; Harper L; Heijl C; HOGlund P; Jayne D; Luqmani R; et alMahr A; Mukhtyar C; Pusey C; Rasmussen N; Westman K. (1 Jun 2009). Long-term survival of ANCA-associated vasculitis. APMIS. 117:139-139. Author weblink.
  • van Wijngaarden RDL; Hauer H; Flossmann O; Jayne D; Gaskin G; Rasmussen N; Noel L-H; Ferrario F; et alWaldherr R; Pusey C; Hagen EC; Bruijn J; Bajema I. (1 Jun 2009). ENT involvement is related to better renal function in patients with ANCA-associated vasculitis. APMIS. 117:138-138. Author weblink.
  • Nogueira E; Hamour S; Tyagi D; Mosely K; Chavele K-M; Pusey CD; Salama AD. (1 Jun 2009). Serum IL-17 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. APMIS. 117:128-129. Author weblink.
  • Sangha G; Al-Ani B; Al-Nuaimi H; Mukherjee S; Salama A; Pusey C; Little M. (1 Jun 2009). Absence of myeloperoxidase renal deposition in rat experimental autoimmune vasculitis. APMIS. 117:88-88. Author weblink.
  • Harper L; De Groot K; Jayne D; Flores Suarez LF; Gregorini G; Gross W; Luqmani R; Pusey C; et alRasmussen N; Sinico R; Tesar V; Vanhille P; Westman K; Savage C. (1 Jun 2009). Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial. APMIS. 117:77-77. Author weblink.
  • Kai A; Espinel-Costoso L; Trivedi S; Casal A; Morgan M; Levy J; Little MA; Pusey C; et alJayne D; Salama AD. (1 Jun 2009). Outcomes of a UK cohort of AAV patients treated with TNF blockade. APMIS. 117:74-74. Author weblink.
  • Mansfield N; Hamour S; Nogueira E; Habib A-M; Pusey C; Cairns T; Griffith M; Levy J; et alGaskin G; Salama AD. (1 Jun 2009). CycLowVas: a rituximab (RTX)-based cyclophosphamide (CYP)-sparing regime. APMIS. 117:69-70. Author weblink.
  • Pepper R; Griffith M; Kirwan C; Levy J; Taube D; Pusey C; Lightstone L; Cairns T. (Dec 2009). Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids. Nephrol Dial Transplant. 24:3717-3723. DOI.
  • Salama AD; Pusey CD. (1 Jul 2009). Shining a LAMP on pauci-immune focal segmental glomerulonephritis. KIDNEY INTERNATIONAL. 76:15-17. Author weblink DOI.
  • Taylor SRJ; Gonzalez-Begne M; Sojka DK; Richardson JC; Sheardown SA; Harrison SM; Pusey CD; Tam FWK; et alElliott JI. (1 Jun 2009). Lymphocytes from P2X(7)-deficient mice exhibit enhanced P2X(7) responses. JOURNAL OF LEUKOCYTE BIOLOGY. 85:978-986. Author weblink DOI.
  • de Groot K; Harper L; Jayne DRW; Suarez LFF; Gregorini G; Gross WL; Luqmani R; Pusey CD; et alRasmussen N; Sinico RA; Tesar V; Vanhille P; Westman K; Savage COS. (19 May 2009). Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial. ANNALS OF INTERNAL MEDICINE. 150:670-U3. Author weblink.
  • Taylor SRJ; Salama AD; Joshi L; Pusey CD; Lightman SL. (1 May 2009). Rituximab Is Effective in the Treatment of Refractory Ophthalmic Wegener's Granulomatosis. ARTHRITIS AND RHEUMATISM. 60:1540-1547. Author weblink DOI.
  • Reynolds J; Abbott DS; Karegli J; Evans DJ; Pusey CD. (Jun 2009). Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis. Am J Pathol. 174:2202-2210. DOI.
  • Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH. (Jul 2009). Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine. 47:37-42. DOI.
  • Taylor SR; Turner CM; Elliott JI; McDaid J; Hewitt R; Smith J; Pickering MC; Whitehouse DL; et alCook HT; Burnstock G; Pusey CD; Unwin RJ; Tam FW. (Jun 2009). P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J Am Soc Nephrol. 20:1275-1281. DOI.
  • Gordon C; Jayne D; Pusey C; Adu D; Amoura Z; Aringer M; Ballerin J; Cervera R; et alCalvo-Alen J; Chizzolini C; Dayer JM; Doria A; Ferrario F; Floege J; Guillevin L; Haubitz M; Hiepe F; Houssiau F; Lesavre P; Lightstone L; Meroni PL; Meyer O; Moulin B; O'Reilly K; Praga M; Schulze-Koops H; Sinico RA; Smith KGC; Tincani A; Vasconcelos C; Hughes G. (1 Mar 2009). European consensus statement on the terminology used in the management of lupus glomerulonephritis. LUPUS. 18:257-263. Author weblink DOI.
  • Little MA; Smyth L; Salama AD; Mukherjee S; Smith J; Haskard D; Nourshargh S; Cook HT; et alPusey CD. (Apr 2009). Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol. 174:1212-1220. DOI.
  • Joshi L; Hamour S; Salama AD; Pusey CD; Lightman S; Taylor SR. (Mar 2009). Renal & ocular targets for therapy in Wegener's granulomatosis. Inflamm Allergy Drug Targets. 8:70-79.
  • Lutz J; Luong LA; Strobl M; Deng M; Huang H; Anton M; Zakkar M; Enesa K; et alChaudhury H; Haskard DO; Baumann M; Boyle J; Harten S; Maxwell PH; Pusey C; Heemann U; Evans PC. (1 Dec 2008). The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. JOURNAL OF MOLECULAR MEDICINE-JMM. 86:1329-1339. Author weblink DOI.
  • Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD. (Feb 2009). Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis. Clin Exp Immunol. 155:311-319. DOI.
  • Segal T; Webb EA; Viner R; Pusey C; Wild G; Allgrove J. (1 Jun 2008). Severe insulin resistance secondary to insulin antibodies: successful treatment with the immunosuppressant MMF. PEDIATRIC DIABETES. 9:250-254. Author weblink DOI.
  • Pepper RJ; Fabre MA; Pavesio C; Gaskin G; Jones RB; Jayne D; Pusey CD; Salama AD. (Jul 2008). Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford). 47:1104-1105. DOI.
  • Behmoaras J; Bhangal G; Smith J; McDonald K; Mutch B; Lai PC; Domin J; Game L; et alSalama A; Foxwell BM; Pusey CD; Cook HT; Aitman TJ. (1 May 2008). Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility. NATURE GENETICS. 40:553-559. Author weblink DOI.
  • Salama AD; Cook HT; Pusey CD; Pepper RJ. (1 Mar 2008). A case of treated ANCA-associated vasculitis with recurrent renal failure. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 3:637-645. Author weblink DOI.
  • Harper L; Kashiwagi Y; Pusey CD; Hendry BM; Domin J. (1 Jan 2007). Platelet-derived growth factor reorganizes the actin cytoskeleton through 3-phosphoinositide-dependent and 3-phosphoinositide-independent mechanisms in human mesangial cells. NEPHRON PHYSIOLOGY. 107:P45-P56. Author weblink DOI.
  • Guillot PV; Cook HT; Pusey CD; Fisk NM; Harten S; Moss J; Shore I; Bou-Gharios G. (Apr 2008). Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol. 214:627-636. DOI.
  • Satchell SC; Buchatska O; Khan SB; Bhangal G; Tasman CH; Saleem MA; Baker DP; Lobb RR; et alSmith J; Cook HT; Mathieson PW; Pusey CD. (Nov 2007). Interferon-beta reduces proteinuria in experimental glomerulonephritis. J Am Soc Nephrol. 18:2875-2884. DOI.
  • Jayne DRW; Gaskin G; Rasmussen N; Abramowicz D; Ferrario F; Guillevin L; Mirapeix E; Savage COS; et alSinico RA; Stegeman CA; Westman KW; van der Woude FJ; van Wijngaarden RAFDL; Pusey CD. (1 Jul 2007). Randomized trial of plasma exchange or high-dosage Methylprednisolone as adjunctive therapy for severe renal vasculitis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 18:2180-2188. Author weblink DOI.
  • Laing CM; Roberts R; Lightstone L; Graham A; Cook TH; Summers S; Pusey CD. (7 Jul 2007). A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case progression. BRITISH MEDICAL JOURNAL. 335:44-44. Author weblink DOI.
  • Pusey C. (1 Sep 2007). The pathogenesis of vascular inflammation by anti-neutrophil cytoplasm antibodies. PEDIATRIC NEPHROLOGY. 22:1427-1427. Author weblink.
  • Laing CM; Roberts R; Lightstone L; Graham A; Cook TH; Summers S; Pusey CD. (28 Jul 2007). A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case outcome. BMJ. 335:205-206. DOI.
  • Laing CM; Roberts R; Lightstone L; Graham A; Cook TH; Summers S; Pusey CD. (30 Jun 2007). Interactive case report - A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case presentation. BRITISH MEDICAL JOURNAL. 334:1372-1372. Author weblink DOI.
  • Nouraei SA; Obholzer R; Ind PW; Salama AD; Pusey CD; Porter F; Howard DJ; Sandhu GS. (Jan 2008). Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis. Thorax. 63:49-52. DOI.
  • Fanciulli M; Norsworthy PJ; Petretto E; Dong R; Harper L; Kamesh L; Heward JM; Gough SC; et alde Smith A; Blakemore AI; Froguel P; Owen CJ; Pearce SH; Teixeira L; Guillevin L; Graham DS; Pusey CD; Cook HT; Vyse TJ; Aitman TJ. (Jun 2007). FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 39:721-723. DOI.
  • Salama A; Ryba M; Levy J; Gaskin G; Pusey C. (1 Jan 2007). Long-term outcome of patients with severe ANCA associated vasculitis treated with plasmapheresis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 25:S118-S118. Author weblink.
  • Salama A; Pusey C; Jayne D; Mosley K. (1 Jan 2007). ABAVAS: A trial of CTLA4Ig in ANCA vasculitis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 25:S114-S114. Author weblink.
  • Smith J; Lai PC; Behmoaras J; Roufosse C; Bhangal G; McDaid JP; Aitman T; Tam FW; et alPusey CD; Cook HT. (Jun 2007). Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J Am Soc Nephrol. 18:1816-1823. DOI.
  • Sheryanna A; Bhangal G; McDaid J; Smith J; Manning A; Foxwell BM; Feldmann M; Cook HT; et alPusey CD; Tam FW. (Apr 2007). Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol. 18:1167-1179. DOI.
  • Poulsom R; Prodromidi EI; Pusey CD; Cook HT. (1 Dec 2006). Cell therapy for renal regeneration-time for some joined-up thinking?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 21:3349-3353. Author weblink DOI.
  • Turner CM; Tam FW; Lai PC; Tarzi RM; Burnstock G; Pusey CD; Cook HT; Unwin RJ. (Feb 2007). Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant. 22:386-395. DOI.
  • Mosley K; Tam FW; Edwards RJ; Crozier J; Pusey CD; Lightstone L. (Dec 2006). Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford). 45:1497-1504. DOI.
  • Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD. (1 Sep 2006). Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION. 21:2671-2672. Author weblink DOI.
  • Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; et alGregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C; European Vasculitis Study Group. (3 Jul 2003). A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 349:36-44. DOI.
  • LANHAM JG; ELKON KB; PUSEY C; HUGHES GRV. (1 Jan 1983). SYSTEMIC VASCULITIS WITH ASTHMA AND EOSINOPHILIA - THE CHURG-STRAUSS-SYNDROME. ANNALS OF THE RHEUMATIC DISEASES. 42:218-218. Author weblink.
  • TAUBE D; HARRINGTON JT; REES A; NEILD G; MALLICK N; BOULTONJONES M; VENNING M; PUSEY C; et alCAMERON JS; JONES M; WING A; DONOHOE J; GABRIEL R. (1 Aug 1990). IMMUNOADSORPTION IN THE SENSITIZED TRANSPLANT RECIPIENT. KIDNEY INTERNATIONAL. 38:350-358. Author weblink DOI.
  • Ebrahim H; Pfeilshifter J; Cook T; Pusey C; Tam F; Cattell V. (1 Nov 1996). In vivo induction of iNOS in glomeruli by the cytokine IL-1 beta. KIDNEY INTERNATIONAL. 50:1804-1804. Author weblink.
  • Arlett PR; Scott J; Hughes JMB; Cohen J; Rogers T; Bloom SR; Pusey C; Friedland JS; et alLynn WA. (2 Nov 1996). Grand rounds - Hammersmith Hospital - A case of laboratory acquired brucellosis - A rare condition, but laboratory transmission is a risk. BRITISH MEDICAL JOURNAL. 313:1130-1132. Author weblink.
  • Allen A; Pusey C; Gaskin G. (1 Jun 1999). Outcome of renal replacement therapy in ANCA-associated systemic vasculitis. KIDNEY INTERNATIONAL. 55:2568-2568. Author weblink.
  • Allen A; Smith J; Cook T; Pusey C. (1 Jun 1999). Blockade of very late antigen-4 reduces renal injury in a rat model of nephrotoxic nephritis. KIDNEY INTERNATIONAL. 55:2557-2558. Author weblink.
  • Savage COS; Harrington JT; Saville J; Rees A; Duffield J; Dillon M; Watson A; Powis S; et alPusey C; Davison A; Iggo N; Reaich D; Roberts I; Mathieson P; Bone J; Stuart L; Gaskin G; Whitworth C; Ritz E. (1 Oct 2001). ANCA-associated renal vasculitis. KIDNEY INTERNATIONAL. 60:1614-1627. Author weblink DOI.
  • Forbes SJ; Wyles SM; Ryan ED; Navaratnarasah S; Hodivala-Dilke KM; Jeffrey R; Hunt T; Alison MR; et alCook T; Pusey C; Poulsom R; Wright NA. (1 Sep 2001). Kidney from bone marrow in humans and mice. JOURNAL OF PATHOLOGY. 195:3A-3A. Author weblink.
  • Lai PC; Smith J; Chaudhry K; Chaudhry A; Keith J; Tam F; Pusey C; Cook T. (1 Sep 2002). Interleukin 11 (IL-11) reduces renal injury and glomerular NF kappa B activity in experimental murine glomerulonephritis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:133A-133A. Author weblink.
  • Booth A; Harper L; Hammad T; Bacon P; Griffith M; Levy J; Savage C; Pusey C; et alJayne D. (1 Mar 2004). Prospective study of TNF alpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 15:717-721. Author weblink DOI.
  • Pusey C; Thakker R. (1 Nov 2004). Clinical academic medicine: the way forward. CLINICAL MEDICINE. 4:483-488. Author weblink.
  • Pusey C; Thakker R. (1 Apr 2005). Is there a future for academic medicine in the UK?. HOSPITAL MEDICINE. 66:198-199. Author weblink.
  • Watts R; Harper L; Jayne D; Levy J; Pusey C; Savage C; Scott DGI; Williams J. (1 May 2005). Translational research in autoimmunity: aims of therapy in vasculitis. RHEUMATOLOGY. 44:573-576. Author weblink DOI.
  • Feehally J; Harrington JT; Bello AK; Gorovich A; Pierides A; Pusey C; Tomson C; Winearls CG; et alWilliams G; Duffield J; Lightstone L; World MJ; Naish P; Feest T. (1 Jul 2005). Ethnicity and renal disease. KIDNEY INTERNATIONAL. 68:414-424. Author weblink.
  • George A; Tokars JI; Clutterbuck EJ; Bamford KB; Pusey C; Holmes AH. (17 Jun 2006). Quality improvement report - Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. BRITISH MEDICAL JOURNAL. 332:1435-1437. Author weblink DOI.
  • Gaskin G; Pusey C. (1992). Immunology of systemic vasculitis. Ann Med Interne (Paris). 143 Suppl 1:57-62.
  • Allen A; Clutterbuck E; Maidment G; Thompson E; Watts R; Pusey C. (Apr 1997). Enteric hyperoxaluria and renal failure associated with lymphangiectasia. Nephrol Dial Transplant. 12:802-806.
  • Allen A; Pusey C; Gaskin G. (Jul 1998). Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol. 9:1258-1263.
  • Glynne P; Deacon A; Goldsmith D; Pusey C; Clutterbuck E. (Jul 1999). Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria?. Am J Kidney Dis. 34:155-160. DOI.
  • George A; Tokars JI; Clutterbuck EJ; Bamford KB; Pusey C; Holmes AH. (17 Jun 2006). Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. BMJ. 332:1435. DOI.
  • Coker R; Kiani-Alikhan S; Stewart A; Pusey C; Dale RG; Jones B. (2006). Plasma TGFbeta1 during pelvic radiotherapy for gynaecological malignancy. Acta Oncol. 45:753-754. DOI.
  • Chen L; Hellmark T; Pedchenko V; Hudson BG; Pusey CD; Fox JW; Bolton WK. (Nov 2006). A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol. 17:3076-3081. DOI.
  • Reynolds J; Albouainain A; Duda MA; Evans DJ; Pusey CD. (Dec 2006). Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transplant. 21:3398-3408. DOI.
  • Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT. (Nov 2006). Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells. 24:2448-2455. DOI.
  • Feldmann M; Pusey CD. (May 2006). Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases. J Am Soc Nephrol. 17:1243-1252. DOI.
  • Pusey CD. (May 2006). The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis. J Am Soc Nephrol. 17:1221-1223. DOI.
  • Salama AD; Pusey CD. (1 Apr 2006). Drug insight: rituximab in renal disease and transplantation. NATURE CLINICAL PRACTICE NEPHROLOGY. 2:221-230. Author weblink DOI.
  • Aitman TJ; Dong R; Vyse TJ; Norsworthy PJ; Johnson MD; Smith J; Mangion J; Roberton-Lowe C; et alMarshall AJ; Petretto E; Hodges MD; Bhangal G; Patel SG; Sheehan-Rooney K; Duda M; Cook PR; Evans DJ; Domin J; Flint J; Boyle JJ; Pusey CD; Cook HT. (16 Feb 2006). Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 439:851-855. DOI.
  • Little MA; Bhangal G; Smyth CL; Nakada MT; Cook HT; Nourshargh S; Pusey CD. (Jan 2006). Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J Am Soc Nephrol. 17:160-169. DOI.
  • Ambrose LR; Little MA; Nourshargh S; Pusey CD. (1 Dec 2005). Anti-proteinase 3 antibody binding to neutrophils as demonstrated by confocal microscopy. KIDNEY INTERNATIONAL. 68:2912-2913. Author weblink DOI.
  • Little MA; Pusey CD; Nourshargh S. (Dec 2005). Intravital microscopy in the study of ANCA-associated systemic vasculitis. Clin Nephrol. 64:465-470.
  • Little MA; Smyth CL; Yadav R; Ambrose L; Cook HT; Nourshargh S; Pusey CD. (15 Sep 2005). Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood. 106:2050-2058. DOI.
  • Little MA; Pusey CD. (Aug 2005). Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management. Nephrology (Carlton). 10:368-376. DOI.
  • Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD. (May 2005). Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int. 67:1812-1820. DOI.
  • Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD. (May 2005). Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol. 16:1350-1359. DOI.
  • Lai PC; Smith J; Bhangal G; Chaudhry KA; Chaudhry AN; Keith JC; Tam FW; Pusey CD; et alCook HT. (2005). Interleukin-11 reduces renal injury and glomerular NF-kappa B activity in murine experimental glomerulonephritis. Nephron Exp Nephrol. 101:e146-e154. DOI.
  • Arlt VM; Hollstein M; Roufosse C; Pusey CD; Cook T; Schmeiser HH; Lord GM. (1 Nov 2004). DNA adducts and p53 mutations in aristolochic acid nephropathy: a UK report. MUTAGENESIS. 19:511-511.
  • Little MA; Pusey CD. (Nov 2004). Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol. 17 Suppl 8:S10-S19.
  • Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; et alGaskin G; Levy JB; Pusey CD. (Nov 2004). Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant. 19:2761-2768. DOI.
  • Reynolds J; Khan SB; Allen AR; Benjamin CD; Pusey CD. (Oct 2004). Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int. 66:1444-1452. DOI.
  • Levy JB; Hammad T; Coulthart A; Dougan T; Pusey CD. (Oct 2004). Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 66:1535-1540. DOI.
  • Smyth L; Gaskin G; Pusey CD. (Oct 2004). Microscopic polyangiitis. Semin Respir Crit Care Med. 25:523-533. DOI.
  • Booth AD; Pusey CD; Jayne DR. (Aug 2004). Renal vasculitis--an update in 2004. Nephrol Dial Transplant. 19:1964-1968. DOI.
  • Lord GM; Hollstein M; Arlt VM; Roufosse C; Pusey CD; Cook T; Schmeiser HH. (1 Apr 2004). DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. AMERICAN JOURNAL OF KIDNEY DISEASES. 43. Author weblink DOI.
  • Tarzi RM; Cook HT; Jackson I; Pusey CD; Lord GM. (Feb 2004). Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol. 164:385-390. DOI.
  • Browne G; Brown PA; Tomson CR; Fleming S; Allen A; Herriot R; Pusey CD; Rees AJ; et alTurner AN. (Feb 2004). Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int. 65:675-681. DOI.
  • Walters G; Habib AM; Reynolds J; Wu H; Knight JF; Pusey CD. (2004). Glomerular T cells are of restricted clonality and express multiple CDR3 motifs across different Vbeta T-cell receptor families in experimental autoimmune glomerulonephritis. Nephron Exp Nephrol. 98:e71-e81. DOI.
  • Baker RJ; Pusey CD. (Jan 2004). The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 19:8-11.
  • Salama AD; Chaudhry AN; Holthaus KA; Mosley K; Kalluri R; Sayegh MH; Lechler RI; Pusey CD; et alLightstone L. (Nov 2003). Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int. 64:1685-1694. DOI.
  • Pusey CD. (Oct 2003). Anti-glomerular basement membrane disease. Kidney Int. 64:1535-1550. DOI.
  • Robson MG; Cook HT; Pusey CD; Walport MJ; Davies KA. (Sep 2003). Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background. Clin Exp Immunol. 133:326-333.
  • Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; et alWoodrow DF; Pusey CD. (May 2003). The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. J Pathol. 200:118-129. DOI.
  • Booth AD; Almond MK; Burns A; Ellis P; Gaskin G; Neild GH; Plaisance M; Pusey CD; et alJayne DR; Pan-Thames Renal Research Group. (Apr 2003). Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 41:776-784.
  • Khan SB; Allen AR; Bhangal G; Smith J; Lobb RR; Cook HT; Pusey CD. (2003). Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis. Nephron Exp Nephrol. 95:e100-e110. DOI.
  • Evans DJ; Macanovic M; Dunn MJ; Pusey CD. (2003). Membranous glomerulonephritis associated with follicular B-cell lymphoma and subepithelial deposition of IgG1-kappa paraprotein. Nephron Clin Pract. 93:c112-c118. DOI.
  • Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD. (Oct 2002). Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Am J Pathol. 161:1265-1272. DOI.
  • Nishino T; Pusey CD; Domin J. (13 Sep 2002). Elevated Akt phosphorylation as an indicator of renal tubular epithelial cell stress. J Biol Chem. 277:33943-33949. DOI.
  • Smyth CL; Pusey CD; Haskard DO. (1 Sep 2002). ANCA induce leucocyte adhesion to endothelial cells mediated by E-selectin and integrins under conditions of flow. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:170A-170A. Author weblink.
  • Smyth CL; Smith J; Cook HT; Haskard DO; Pusey CD. (1 Sep 2002). Immunisation with MPO directly induces small vessel vasculitis with Pauci-immune focal segmental glomerulonephritis and alveolar haemorrhage in WKY rats. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:170A-170A. Author weblink.
  • Habib AMN; Levy JB; Reynolds JR; Walters G; Knight JF; Pusey CD. (1 Sep 2002). Oligoclonal T cells in glomeruli of rats with experimental autoimmune glomerulonephritis (EAG). JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:172A-172A. Author weblink.
  • Boyle JJ; Smith J; Pusey CD; Cook HT. (1 Sep 2002). Susceptibility of WKY rats to glomerulonephritis is associated with enhanced macrophage killing of mesangial cells mediated via nitric oxide and phospholipase C. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:49A-49A. Author weblink.
  • Salama AD; Chaudhry A; Sayegh MH; Lechler RI; Pusey CD; Lightstone L. (1 Sep 2002). The role of CD25+regulatory cells in restoring tolerance in autoimmune anti-GBM (Goodpasture's) disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:664A-664A. Author weblink.
  • Norden AG; Lapsley M; Lee PJ; Pusey CD; Scheinman SJ; Tam FW; Thakker RV; Unwin RJ; et alWrong O. (Jul 2002). Fragmentation of filtered proteins and implications for glomerular protein sieving in Fanconi syndrome. Kidney Int. 62:349. DOI.
  • Dougan T; Levy JB; Salama A; George AJ; Pusey CD. (Jun 2002). Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor. Clin Exp Immunol. 128:555-561.
  • Salama AD; Dougan T; Levy JB; Cook HT; Morgan SH; Naudeer S; Maidment G; George AJ; et alEvans D; Lightstone L; Pusey CD. (Jun 2002). Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis. 39:1162-1167. DOI.
  • Pusey CD. (May 2002). Careers in academic medicine: the clinician scientist scheme. Clin Med. 2:179-181.
  • Salama AD; Pusey CD. (1 May 2002). Immunology of anti-glomerular basement membrane. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 11:279-286. Author weblink DOI.
  • Salama AD; Pusey CD. (May 2002). Immunology of anti-glomerular basement membrane disease. Curr Opin Nephrol Hypertens. 11:279-286.
  • Pusey CD. (9 Mar 2002). Commentary: Iloprost for cholesterol emboli syndrome. BMJ. 324:609.
  • Pusey CD. (9 Mar 2002). Effectiveness of smoking cessation initiatives - Commentary: Iloprost for cholesterol emboli syndrome. BRITISH MEDICAL JOURNAL. 324:609-609. Author weblink DOI.
  • Lord GM; Pusey CD. (2 Mar 2002). Chinese herbal nephropathy - Reply. LANCET. 359:796-797. Author weblink DOI.
  • Cronin AJ; Maidment G; Cook T; Kite GC; Simmonds MS; Pusey CD; Lord GM. (Mar 2002). Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transplant. 17:524-525.
  • Reynolds J; Norgan VA; Bhambra U; Smith J; Cook HT; Pusey CD. (Feb 2002). Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol. 13:359-369.
  • Reynolds J; Cook PR; Ryan JJ; Norsworthy PJ; Glazier AM; Duda MA; Evans DJ; Aitman TJ; et alPusey CD. (2002). Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of Col4a3 as a candidate gene. Exp Nephrol. 10:402-407.
  • Reynolds J; Pusey CD. (1 Dec 2001). T-cell-specific therapy in autoimmune glomerulonephritis - Authors reply. AMERICAN JOURNAL OF KIDNEY DISEASES. 38:1324-1328. Author weblink DOI.
  • Lord GM; Cook T; Arlt VM; Schmeiser HH; Williams G; Pusey CD. (3 Nov 2001). Urothelial malignant disease and Chinese herbal nephropathy. Lancet. 358:1515-1516.
  • Norden AG; Lapsley M; Lee PJ; Pusey CD; Scheinman SJ; Tam FW; Thakker RV; Unwin RJ; et alWrong O. (Nov 2001). Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 60:1885-1892. DOI.
  • Lai PC; Cook HT; Smith J; Keith JC; Pusey CD; Tam FW. (Nov 2001). Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats. J Am Soc Nephrol. 12:2310-2320.
  • Stone JH; Calabrese LH; Hoffman GS; Pusey CD; Hunder GG; Hellmann DB. (1 Nov 2001). Vasculitis - A collection of pearls and myths. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 27:677-+. Author weblink DOI.
  • Salama AD; Levy JB; Lightstone L; Pusey CD. (15 Sep 2001). Goodpasture's disease. Lancet. 358:917-920. DOI.
  • Poulsom R; Forbes SJ; Hodivala-Dilke K; Ryan E; Wyles S; Navaratnarasah S; Jeffery R; Hunt T; et alAlison M; Cook T; Pusey C; Wright NA. (Sep 2001). Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 195:229-235. DOI.
  • Salama AD; Chaudhry AN; Ryan JJ; Eren E; Levy JB; Pusey CD; Lightstone L; Lechler RI. (Sep 2001). In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol. 12:1908-1915.
  • Salama AD; Delikouras A; Pusey CD; Cook HT; Bhangal G; Lechler RI; Dorling A. (Sep 2001). Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant. 1:260-269.
  • Levy JB; Turner AN; Rees AJ; Pusey CD. (5 Jun 2001). Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 134:1033-1042.
  • Robson MG; Cook HT; Botto M; Taylor PR; Busso N; Salvi R; Pusey CD; Walport MJ; et alDavies KA. (1 Jun 2001). Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol. 166:6820-6828.
  • Gaskin G; Pusey CD. (Jun 2001). Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Ther Apher. 5:176-181.
  • Karkar AM; Smith J; Pusey CD. (Mar 2001). Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha. Nephrol Dial Transplant. 16:518-524.
  • Ryan JJ; Reynolds J; Norgan VA; Pusey CD. (Feb 2001). Expression and characterization of recombinant rat alpha 3(IV)NC1 and its use in induction of experimental autoimmune glomerulonephritis. Nephrol Dial Transplant. 16:253-261.
  • Ryan CJ; Anilkumar T; Ben-Hamida AJ; Khorsandi SE; Aslam M; Pusey CD; Gaylor JD; Courtney JM. (Feb 2001). Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. Artif Organs. 25:109-118.
  • Griffith ME; Coulthart A; Pemberton S; George AJ; Pusey CD. (Jan 2001). Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site. Clin Exp Immunol. 123:170-177.
  • Griffith ME; Pusey CD. (2001). Cellular aspects of vasculitis--T cell-mediated aspects. Springer Semin Immunopathol. 23:287-298.
  • Reynolds J; Pusey CD. (Jan 2001). Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol. 12:61-70.
  • Levy JB; Pusey CD. (Nov 2000). Nephrotoxicity of intravenous immunoglobulin. QJM. 93:751-755.
  • Dupont PJ; Lightstone L; Clutterbuck EJ; Gaskin G; Pusey CD; Cook T; Warrens AN. (28 Oct 2000). Lesson of the week: cholesterol emboli syndrome. BMJ. 321:1065-1067.
  • Reynolds J; Tam FW; Chandraker A; Smith J; Karkar AM; Cross J; Peach R; Sayegh MH; et alPusey CD. (Mar 2000). CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest. 105:643-651. DOI.
  • Watts RA; Scott DGI; Pusey CD; Lockwood CM. (1 Mar 2000). Vasculitis - aims of therapy. An overview. RHEUMATOLOGY. 39:229-232. Author weblink DOI.
  • Tam FW; Smith J; Agarwal S; Karkar AM; Morel D; Thompson EM; Pusey CD. (Jan 2000). Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis. Nephron. 84:58-66.
  • Lord GM; Tagore R; Cook T; Gower P; Pusey CD. (7 Aug 1999). Nephropathy caused by Chinese herbs in the Uh. LANCET. 354:481-482. Author weblink DOI.
  • Tam FW; Smith J; Morel D; Karkar AM; Thompson EM; Cook HT; Pusey CD. (Jul 1999). Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. Nephrol Dial Transplant. 14:1658-1666.
  • Baker RJ; Salama AD; Chaudhry AN; Cook HT; Pusey CD. (1 Jun 1999). Acute tubulointerstitial nephritis - a clinicopathological study of 22 patients. KIDNEY INTERNATIONAL. 55:2591-2591. Author weblink.
  • Robson MG; Cook HT; Botto M; Pusey CD; Walport MJ; Davies KA. (1 Jun 1999). C1q deficient mice develop severe disease in accelerated nephrotoxic nephritis. KIDNEY INTERNATIONAL. 55:2593-2593. Author weblink.
  • Robson MG; Cook HT; Botto M; Pusey CD; Walport MJ; Davies KA. (1 Jun 1999). C1q deficient mice have delayed resolution of inflammation in heterologous nephrotoxic nephritis. KIDNEY INTERNATIONAL. 55:2580-2580. Author weblink.
  • Gaskin G; Pusey CD. (1 Jun 1999). Long-term outcome after plasma exchange and immunosuppression for severe vasculitis-associated glomerulonephritis. KIDNEY INTERNATIONAL. 55:2593-2593. Author weblink.
  • Lai PC; Cook HT; Tam FWK; Smith J; Pusey CD. (1 Jun 1999). Recombinant interleukin-11 is effective in ameliorating glomerulonephritis in Wistar-Kyoto rats. KIDNEY INTERNATIONAL. 55:2579-2579. Author weblink.
  • Karkar AM; Allen A; Cook T; Smith J; Fawell S; Loveday K; Pusey CD. (1 Jun 1999). Therapeutic effect of osteogenic protein-1 in experimental crescentic nephritis. KIDNEY INTERNATIONAL. 55:2555-2555. Author weblink.
  • Reynolds J; Moss J; Smith J; Karkar AM; Shore I; Evans DJ; Woodrow DF; Pusey CD. (1 Jun 1999). Ultrastructural abnormalities of kidney and lung in a rat model of Goodpasture's disease. KIDNEY INTERNATIONAL. 55:2557-2557. Author weblink.
  • Reynolds J; Nour DA; Pusey CD. (1 May 1999). A mouse model of experimental autoimmune glomerulonephritis (EAG). KIDNEY INTERNATIONAL. 55:2095-2096. Author weblink.
  • Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD. (1 May 1999). Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J Immunol. 162:5519-5527.
  • Karkar AM; Smith J; Tam FWK; Pusey CD. (1 May 1999). Prevention of acute inflammation and crescent formation in experimental crescentic nephritis by blocking tumour necrosis factor-alpha (TNF-alpha). KIDNEY INTERNATIONAL. 55:2103-2104. Author weblink.
  • Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD. (Apr 1999). Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Kidney Int. 55:1319-1326. DOI.
  • Ryan JJ; Mason PJ; Pusey CD; Turner N. (Jul 1998). Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition. Clin Exp Immunol. 113:17-27.
  • Salama AD; Pusey CD. (25 Jun 1998). Images in clinical medicine. Tuberous sclerosis. N Engl J Med. 338:1886. DOI.
  • Salama AD; Pusey CD. (25 Jun 1998). Tuberous sclerosis. NEW ENGLAND JOURNAL OF MEDICINE. 338:1886-1886. Author weblink DOI.
  • Robson MG; Cook HT; Botto M; Pusey CD; Walport MJ; Davies KA. (1 Apr 1998). Accelerated nephrotoxic nephritis: Increased severity of disease in Clq deficient mice. MOLECULAR IMMUNOLOGY. 35:343-343. Author weblink DOI.
  • Robson MG; Cook HT; Botto M; Pusey CD; Walport MJ; Davies KA. (1 Apr 1998). Delayed resolution of inflammation in heterologous nephrotoxic nephritis in Clq deficient mice. MOLECULAR IMMUNOLOGY. 35:343-343. DOI.
  • Karkar AM; Smith J; Tam FW; Pusey CD; Rees AJ. (Nov 1997). Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6. Kidney Int. 52:1313-1320.
  • Tam FW; Smith J; Karkar AM; Pusey CD; Rees AJ. (Nov 1997). Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor. Kidney Int. 52:1224-1231.
  • Levy JB; Coulthart A; Pusey CD. (Nov 1997). Mapping B cell epitopes in Goodpasture's disease. J Am Soc Nephrol. 8:1698-1705.
  • Howard JK; Lord GM; Clutterbuck EJ; Ghatei MA; Pusey CD; Bloom SR. (Aug 1997). Plasma immunoreactive leptin concentration in end-stage renal disease. Clin Sci (Lond). 93:119-126.
  • Reynolds J; Newman VO; Aitman TJ; Evans DJ; Pusey CD. (1 Jul 1997). Genetic analysis of susceptibility to EAG in Wister Kyoto rats. KIDNEY INTERNATIONAL. 52:268-268. Author weblink.
  • Kotanko P; Pusey CD; Levy JB. (27 Apr 1997). Recurrent glomerulonephritis following renal transplantation. Transplantation. 63:1045-1052.
  • Griffith ME; Pusey CD. (1 Jan 1997). HLA genes in ANCA-associated vasculitides. EXPERIMENTAL AND CLINICAL IMMUNOGENETICS. 14:196-205. Author weblink.
  • Gaskin G; Pusey CD. (1 Jan 1997). Plasma exchange is not excluded as a useful therapy in vasculitis-associated glomerulonephritis. ANNALES DE MEDECINE INTERNE. 148:196-197. Author weblink.
  • Levy JB; Pusey CD. (Jan 1997). Still a role for plasma exchange in rapidly progressive glomerulonephritis?. J Nephrol. 10:7-13.
  • Levy JB; Turner AN; George AJ; Pusey CD. (Oct 1996). Epitope analysis of the Goodpasture antigen using a resonant mirror biosensor. Clin Exp Immunol. 106:79-85.
  • Hagen EC; Andrassy K; Csernok E; Daha MR; Gaskin G; Gross WL; Hansen B; Heigl Z; et alHermans J; Jayne D; Kallenberg CGM; Lesavre P; Lockwood CM; Ludemann J; MascartLemone F; Mirapeix E; Pusey CD; Rasmussen N; Sinico RA; Tzioufas A; Wieslander J; Wiik A; VanderWoude FJ. (13 Sep 1996). Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) - A report on the second phase of an international cooperative study on the standardization of ANCA assays. JOURNAL OF IMMUNOLOGICAL METHODS. 196:1-15. Author weblink DOI.
  • Griffith ME; Gaskin G; Pusey CD. (Sep 1996). Classification, pathogenesis, and treatment of systemic vasculitis. Ren Fail. 18:785-802.
  • Morel D; Tam FWK; Smith J; Thompson EM; Yoshimura T; Pusey CD. (1 Sep 1996). Glomerular expression of RANTES and recruitment of CD8+ cells in crescentic glomerulonephritis in WKY rats. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 7:A2322-A2322. Author weblink.
  • Griffith ME; Turner AN; McVey J; Pusey CD. (1 Sep 1996). Production of recombinant proteinase 3 recognised by human autoantibodies. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 7:A2271-A2271. Author weblink.
  • Ussov WY; Peters AM; Savill J; Pusey CD; Gaskin G; Hodgson HJ; Goldman JM; Hughes JM. (Sep 1996). Relationship between granulocyte activation, pulmonary granulocyte kinetics and alveolar permeability in extrapulmonary inflammatory disease. Clin Sci (Lond). 91:329-335.
  • Tam FWK; Smith J; Morel D; Agarwal S; Pusey CD. (1 Sep 1996). Type IV phosphodiesterase inhibitor is effective in both prevention and treatment of progressive experimental glomerulonephritis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 7:A2376-A2376. Author weblink.
  • Ross CN; Turner N; Savage P; Cashman SJ; Spooner RA; Pusey CD. (Jun 1996). A single-chain Fv reactive with the Goodpasture antigen. Lab Invest. 74:1051-1059.
  • Allen AR; Thompson EM; Williams G; Watts RWE; Pusey CD. (1 Jun 1996). Selective renal transplantation in primary hyperoxaluria type 1. AMERICAN JOURNAL OF KIDNEY DISEASES. 27:891-895. Author weblink DOI.
  • Levy JB; Lachmann RH; Pusey CD. (Apr 1996). Recurrent Goodpasture's disease. Am J Kidney Dis. 27:573-578.
  • Griffith ME; Lovegrove JU; Gaskin G; Whitehouse DB; Pusey CD. (Mar 1996). C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant. 11:438-443.
  • Urch C; Pusey CD. (Feb 1996). Sagittal sinus thrombosis in adult minimal change nephrotic syndrome. Clin Nephrol. 45:131-132.
  • Griffith ME; Coulthart A; Pusey CD. (Feb 1996). T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol. 103:253-258.
  • Tam FWK; Pusey CD. (1 Nov 1995). The role of T lymphocytes in extracapillary glomerulonephritis. JOURNAL OF NEPHROLOGY. 8:305-315. Author weblink.
  • BEALES ILP; DAVEY NJ; PUSEY CD; LECHLER RI; CALAM J. (5 Aug 1995). LONG-TERM SEQUELAE OF HELICOBACTER-PYLORI GASTRITIS. LANCET. 346:381-382. Author weblink DOI.
  • Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ. (Aug 1995). Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 7:783-789.
  • DERRY CJ; ROSS CN; LOMBARDI G; MASON PD; REES AJ; LECHLER RI; PUSEY CD. (1 May 1995). ANALYSIS OF T-CELL RESPONSES TO THE AUTOANTIGEN IN GOODPASTURES DISEASE. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 100:262-268. Author weblink.
  • JAYNE DRW; GASKIN C; PUSEY CD; LOCKWOOD CM. (1 Feb 1995). ANCA AND PREDICTING RELAPSE IN SYSTEMIC VASCULITIS. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS. 88:127-133. Author weblink.
  • Burns AP; Fisher M; Li P; Pusey CD; Rees AJ. (Feb 1995). Molecular analysis of HLA class II genes in Goodpasture's disease. QJM. 88:93-100.
  • Katbamna I; Turner N; Ross CN; Pusey CD. (1995). Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains. J Clin Lab Immunol. 47:11-24.
  • Mason PD; Pusey CD. (10 Dec 1994). Glomerulonephritis: diagnosis and treatment. BMJ. 309:1557-1563.
  • TABRIZI SJ; SCOTT J; PUSEY CD; LACEY S; DAVIES RAA; REES AJ; BEYNON H; OAKLEY C; et alWHYTE M. (3 Dec 1994). GRAND ROUNDS - HAMMERSMITH-HOSPITAL - NOCARDIA-PERICARDITIS - A RARE OPPORTUNISTIC INFECTION. BRITISH MEDICAL JOURNAL. 309:1495-1497. Author weblink.
  • GRIFFITH ME; COULTHART A; PUSEY CD. (1 Sep 1994). SPECIFIC T-CELL RESPONSES TO ANCA AUTOANTIGENS IN SYSTEMIC VASCULITIS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 5:749-749. Author weblink.
  • DERRY CJ; PICKERING M; BAKER C; PUSEY CD. (1 Jul 1994). IDENTIFICATION OF THE GOODPASTURE ANTIGEN, ALPHA-3(IV) NC1, AND 4 OTHER NC1 DOMAINS OF TYPE-IV COLLAGEN, BY AMINO-TERMINAL SEQUENCE-ANALYSIS OF HUMAN GLOMERULAR-BASEMENT-MEMBRANE SEPARATED BY 2-DIMENSIONAL ELECTROPHORESIS. EXPERIMENTAL NEPHROLOGY. 2:249-256. Author weblink.
  • USSOV WY; PETERS AM; HUGHES JMB; GLASS DM; GASKIN G; SPENCER A; PUSEY CD; HODGSON HJF. (1 May 1994). PULMONARY VASCULAR GRANULOCYTE KINETICS AND ALVEOLOCAPILLARY BARRIER DAMAGE IN EXTRAPULMONARY INFLAMMATORY CONDITIONS. JOURNAL OF NUCLEAR MEDICINE. 35:P132-P132. Author weblink.
  • Derry CJ; Pusey CD. (1994). Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting. Nephrol Dial Transplant. 9:355-361.
  • Fish DE; Evans DJ; Pusey CD. (Dec 1993). Gallbladder vasculitis: a report of two cases. Histopathology. 23:584-585.
  • Abel PD; Lindsay KS; Lord RH; MacGregor S; Floyd I; Williams G; Pusey CD. (Nov 1993). Effects of plasma exchange on sperm antibody levels in males with subfertility. Br J Urol. 72:820-821.
  • Lord GM; Scott J; Pusey CD; Rees AJ; Walport MJ; Davies KA; Bulpitt C; Bloom SR; et alMuntoni FM. (30 Oct 1993). Diabetes and rhabdomyolysis. A rare complication of a common disease. BMJ. 307:1126-1128.
  • LORD GM; SCOTT J; PUSEY CD; REES AJ; WALPORT MJ; DAVIES KAA; BULPITT C; BLOOM S; et alMUNTONI FM. (30 Oct 1993). GRAND ROUNDS - HAMMERSMITH-HOSPITAL - DIABETES AND RHABDOMYOLYSIS. BRITISH MEDICAL JOURNAL. 307:1126-1128. Author weblink.
  • CHAUDHURI KR; EDWARDS R; SCOTT J; BROOKS DJ; REES A; PUSEY CD. (2 Oct 1993). GRAND ROUNDS - HAMMERSMITH-HOSPITAL - ADULT MOYAMOYA DISEASE. BRITISH MEDICAL JOURNAL. 307:852-854. Author weblink.
  • Burns AP; Hopkins PM; Hall G; Pusey CD. (Jul 1993). Rhabdomyolysis and acute renal failure in unsuspected malignant hyperpyrexia. Q J Med. 86:431-434.
  • Ross CN; Gaskin G; Gregor-Macgregor S; Patel AA; Davey NJ; Lechler RI; Williams G; Rees AJ; et alPusey CD. (Apr 1993). Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation. 55:785-789.
  • HAGEN EC; ANDRASSY K; CHERNOK E; DAHA MR; GASKIN G; GROSS W; LESAVRE P; LUDEMANN J; et alPUSEY CD; RASMUSSEN N; SAVAGE COS; SINICO A; WIIK A; VANDERWOUDE FJ. (26 Feb 1993). THE VALUE OF INDIRECT IMMUNOFLUORESCENCE AND SOLID-PHASE TECHNIQUES FOR ANCA DETECTION - A REPORT ON THE 1ST PHASE OF AN INTERNATIONAL COOPERATIVE STUDY ON THE STANDARDIZATION OF ANCA ASSAYS. JOURNAL OF IMMUNOLOGICAL METHODS. 159:1-16. Author weblink.
  • GASKIN G; PUSEY CD. (1 Feb 1993). ANCA-ASSOCIATED RENAL-DISEASE. QUARTERLY JOURNAL OF MEDICINE. 86:138-139. Author weblink.
  • Pusey CD; Gaskin G. (1993). Disease associations with anti-neutrophil cytoplasmic antibodies. Adv Exp Med Biol. 336:145-155.
  • Jonker ND; Peters AM; Gaskin G; Pusey CD; Lavender JP. (Apr 1992). A retrospective study of radiolabeled granulocyte kinetics in patients with systemic vasculitis. J Nucl Med. 33:491-497.
  • Spencer SJ; Burns A; Gaskin G; Pusey CD; Rees AJ. (Apr 1992). HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int. 41:1059-1063.
  • TURNER N; MASON PJ; BROWN R; REES AJ; PUSEY CD. (1 Mar 1992). CLONING OF THE GOODPASTURE ANTIGEN, THE ALPHA-3-CHAIN OF TYPE-IV COLLAGEN. KIDNEY INTERNATIONAL. 41:704-705.
  • TURNER N; MASON PJ; BROWN R; FOX M; POVEY S; REES A; PUSEY CD. (1 Feb 1992). MOLECULAR-CLONING OF THE HUMAN GOODPASTURE ANTIGEN DEMONSTRATES IT TO BE THE ALPHA-3 CHAIN OF TYPE-IV COLLAGEN. JOURNAL OF CLINICAL INVESTIGATION. 89:592-601. Author weblink DOI.
  • Frankel AH; Singer DR; Winearls CG; Evans DJ; Rees AJ; Pusey CD. (Feb 1992). Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients. Q J Med. 82:101-124.
  • Gregor-MacGregor S; Pusey CD. (1992). Succinylated gelatin as partial fluid replacement in chronic therapeutic plasma exchange. J Clin Apher. 7:124-125.
  • Derry CJ; Dunn MJ; Rees AJ; Pusey CD. (Dec 1991). Restricted specificity of the autoantibody response in Goodpasture's syndrome demonstrated by two-dimensional western blotting. Clin Exp Immunol. 86:457-463.
  • Ross CN; Beynon HL; Savill JS; Watkins RP; Cohen J; Pusey CD; Rees AJ. (Nov 1991). Ganciclovir treatment for cytomegalovirus infection in immunocompromised patients with renal disease. Q J Med. 81:929-936.
  • Pusey CD; Rees AJ; Evans DJ; Peters DK; Lockwood CM. (Oct 1991). Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 40:757-763.
  • SAVAGE COS; POTTINGER BE; GASKIN G; LOCKWOOD CM; PUSEY CD; PEARSON JD. (1 Jul 1991). VASCULAR DAMAGE IN WEGENERS GRANULOMATOSIS AND MICROSCOPIC POLYARTERITIS - PRESENCE OF ANTIENDOTHELIAL CELL ANTIBODIES AND THEIR RELATION TO ANTINEUTROPHIL CYTOPLASM ANTIBODIES. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 85:14-19. Author weblink.
  • GODDARD J; BLOOM S; FRACKOWIAK RSJ; PUSEY CD; MACDERMOT J; LIDDLE PF. (25 May 1991). HAMMERSMITH STAFF ROUNDS - LITHIUM INTOXICATION. BRITISH MEDICAL JOURNAL. 302:1267-1269. Author weblink.
  • Goddard J; Bloom SR; Frackowiak RS; Pusey CD; MacDermot J; Liddle PF. (25 May 1991). Lithium intoxication. BMJ. 302:1267-1269.
  • Li PK; Burns AP; So AK; Pusey CD; Feehally J; Rees AJ. (May 1991). The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int. 39:961-965.
  • Pusey CD; Holland MJ; Cashman SJ; Sinico RA; Lloveras JJ; Evans DJ; Lockwood CM. (1991). Experimental autoimmune glomerulonephritis induced by homologous and isologous glomerular basement membrane in Brown-Norway rats. Nephrol Dial Transplant. 6:457-465.
  • BELLINGAN GJ; BLOOM S; IND PW; PALLIS C; PUSEY CD; FRACKOWIAK RS. (8 Dec 1990). HAMMERSMITH STAFF ROUNDS - DISSEMINATED ACTINOMYCOSIS. BRITISH MEDICAL JOURNAL. 301:1323-1324. Author weblink.
  • Cassidy MJ; Gaskin G; Savill J; Pusey CD; Rees AJ. (11 Aug 1990). Towards a more rapid diagnosis of rapidly progressive glomerulonephritis. BMJ. 301:329-331.
  • ISAACS JD; EVANS DJ; PUSEY CD. (1 Aug 1990). MESANGIAL IGA DISEASE WITH CRESCENT FORMATION DURING PREGNANCY - POSTPARTUM TREATMENT WITH IMMUNOSUPPRESSION. NEPHROLOGY DIALYSIS TRANSPLANTATION. 5:619-622. Author weblink.
  • PUSEY CD; BOWMAN C; MORGAN A; WEETMAN AP; HARTLEY B; LOCKWOOD CM. (1 Jul 1990). KINETICS AND PATHOGENICITY OF AUTOANTIBODIES INDUCED BY MERCURIC-CHLORIDE IN THE BROWN NORWAY RAT. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 81:76-82. Author weblink.
  • ROSS CN; TAM FWK; WINTER RJD; PUSEY CD; REES AJ. (19 May 1990). ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AND SUBGLOTTIC STENOSIS. LANCET. 335:1231-1232. Author weblink DOI.
  • Turner N; Pusey CD. (May 1990). Aortic dissection masquerading as systemic disease--the post-dissection syndrome. Q J Med. 75:525-531.
  • Rees AJ; Pusey CD. (Apr 1990). Plasma exchange in systemic vasculitis. Neth J Med. 36:103-106.
  • Turner AN; Whittaker S; Banks I; Jones RR; Pusey CD. (Mar 1990). Plasma exchange in refractory cutaneous vasculitis. Br J Dermatol. 122:411-415.
  • Ranasinghe WA; Giles CM; Pusey CD; Hows J; Ritter MA; Walport MJ. (1990). Erythroid HLA class I expression in 300 patients with haematological, renal and rheumatological disorders. Vox Sang. 59:55-59.
  • Pusey CD. (1990). Plasma exchange in immunological disease. Prog Clin Biol Res. 337:419-424.
  • Mason PD; Pusey CD. (1990). Plasma exchange in nephrological diseases. Curr Stud Hematol Blood Transfus. 152-166.
  • Clutterbuck EJ; Evans DJ; Pusey CD. (1990). Renal involvement in Churg-Strauss syndrome. Nephrol Dial Transplant. 5:161-167.
  • Savage CO; Cashman SJ; Pusey CD; Evans DJ; Noël LH; Grünfeld JP; Lockwood CM. (1990). Studies on glomerular basement membrane in progressive hereditary nephritis. Contrib Nephrol. 80:68-75.
  • ISHA N; CASHMAN SJ; HAY H; PUSEY CD; EVANS DJ; SHAW A; REES AJ. (1 May 1989). MODULATION OF ANTIBODY-MEDIATED GLOMERULAR INJURY INVIVO BY BACTERIAL LIPOPOLYSACCHARIDE, TUMOR NECROSIS FACTOR, AND IL-1. JOURNAL OF IMMUNOLOGY. 142:3083-3090. Author weblink.
  • Pusey CD; Lockwood CM. (Apr 1989). Autoimmunity in rapidly progressive glomerulonephritis. Kidney Int. 35:929-937.
  • STEVENS PE; PUSEY CD; RAINFORD DJ. (10 Dec 1988). SPRINTING CAN SERIOUSLY DAMAGE YOUR HEALTH. BRITISH MEDICAL JOURNAL. 297:1518-1518. Author weblink.
  • Savage CO; Banks I; Pusey CD. (Oct 1988). Therapeutic applications of plasma exchange. Br J Hosp Med. 40:272-283.
  • SAVAGE COS; BANKS I; PUSEY CD. (1 Oct 1988). THERAPEUTIC APPLICATIONS OF PLASMA-EXCHANGE. BRITISH JOURNAL OF HOSPITAL MEDICINE. 40:272-&. Author weblink.
  • Cashman SJ; Pusey CD; Evans DJ. (May 1988). Extraglomerular distribution of immunoreactive Goodpasture antigen. J Pathol. 155:61-70. DOI.
  • Savill JS; Barrie R; Ghosh S; Muhlemann M; Dawson P; Pusey CD. (May 1988). Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med J. 64:392-394.
  • Savill JS; Chia Y; Pusey CD. (May 1988). Minimal change nephropathy and pemphigus vulgaris associated with penicillamine treatment of rheumatoid arthritis. Clin Nephrol. 29:267-270.
  • BRECKER SJD; PUSEY CD. (1 Feb 1988). NOCARDIA-ASTEROIDES INFECTION OF THE CAUDA-EQUINA. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 51:309-311. Author weblink DOI.
  • Clutterbuck EJ; Pusey CD. (Sep 1987). Severe alveolar haemorrhage in Churg-Strauss syndrome. Eur J Respir Dis. 71:158-163.
  • COHEN J; ASLAM M; PUSEY CD; RYAN CJ. (1 Apr 1987). PROTECTION FROM ENDOTOXEMIA - A RAT MODEL OF PLASMAPHERESIS AND SPECIFIC ADSORPTION WITH POLYMYXIN-B. JOURNAL OF INFECTIOUS DISEASES. 155:690-695. Author weblink.
  • PUSEY CD; DASH A; KERSHAW MJ; MORGAN A; REILLY A; REES AJ; LOCKWOOD CM. (1 Jan 1987). A SINGLE AUTOANTIGEN IN GOODPASTURES-SYNDROME IDENTIFIED BY A MONOCLONAL-ANTIBODY TO HUMAN GLOMERULAR-BASEMENT-MEMBRANE. LABORATORY INVESTIGATION. 56:23-31. Author weblink.
  • Lockwood CM; Savage CO; Pusey CD. (1987). Specific immunoabsorption. Ciba Found Symp. 129:234-257.
  • CASHMAN SJ; PUSEY CD; EVANS DJ. (1 Jul 1986). IMMUNOHISTOCHEMICAL LOCALIZATION OF GOODPASTURE ANTIGEN (GPA) IN EXTRARENAL TISSUES. JOURNAL OF PATHOLOGY. 149:A206-A206. Author weblink.
  • SAVAGE COS; PUSEY CD; KERSHAW MJ; CASHMAN SJ; HARRISON P; HARTLEY B; TURNER DR; CAMERON JS; et alEVANS DJ; LOCKWOOD CM. (1 Jul 1986). THE GOODPASTURE ANTIGEN IN ALPORTS-SYNDROME - STUDIES WITH A MONOCLONAL-ANTIBODY. KIDNEY INTERNATIONAL. 30:107-112. Author weblink DOI.
  • SAVAGE COS; KERSHAW M; PUSEY CD; BARRATT TM; REED A; PINCOTT J; DILLON MJ; LOCKWOOD CM. (28 Jun 1986). USE OF A MONOCLONAL-ANTIBODY IN DIFFERENTIAL-DIAGNOSIS OF CHILDREN WITH HEMATURIA AND HEREDITARY NEPHRITIS. LANCET. 1:1459-1461. Author weblink.
  • RYAN CJ; PUSEY CD; ASLAM M; GAYLOR JDS; MAINI R; COURTNEY JM. (1 Apr 1986). REPEATED MEMBRANE PLASMA SEPARATION WITH ONLINE SORBENT TREATMENT OF PLASMA IN THE CONSCIOUS RAT. ARTIFICIAL ORGANS. 10:135-144. Author weblink DOI.
  • SAVAGE COS; PUSEY CD; BOWMAN C; REES AJ; LOCKWOOD CM. (1 Feb 1986). ANTIGLOMERULAR BASEMENT-MEMBRANE ANTIBODY MEDIATED DISEASE IN THE BRITISH-ISLES 1980-4. BRITISH MEDICAL JOURNAL. 292:301-304. Author weblink.
  • SINGER DRJ; VENNING MC; LOCKWOOD CM; PUSEY CD. (1 Jan 1986). CRYOGLOBULINEMIA - CLINICAL-FEATURES AND RESPONSE TO TREATMENT. ANNALES DE MEDECINE INTERNE. 137:251-253. Author weblink.
  • SINGER DRJ; VENNING MC; PUSEY CD; LOCKWOOD CM. (1 Jan 1985). MIXED ESSENTIAL CRYOGLOBULINEMIA - CLINICAL-FEATURES AND RESPONSE TO TREATMENT. KIDNEY INTERNATIONAL. 28:298-298. Author weblink.
  • WALPORT MJ; PETERS AM; ELKON KB; PUSEY CD; LAVENDER JP; HUGHES GRV. (1 Jan 1985). THE SPLENIC EXTRACTION RATIO OF ANTIBODY-COATED ERYTHROCYTES AND ITS RESPONSE TO PLASMA-EXCHANGE AND PULSE METHYLPREDNISOLONE. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 60:465-473. Author weblink.
  • PUSEY CD. (1 Jan 1984). CLINICAL IMMUNOLOGY OF THE KIDNEY - ZABRISKIE,JB, FILLIT,H, VILLARREAL,H, BECKER,EL. LANCET. 1:428-429. Author weblink.
  • HAWORTH SJ; PUSEY CD. (1 Jan 1984). SEVERE INTESTINAL INVOLVEMENT IN WEGENER GRANULOMATOSIS. GUT. 25:1296-1300. Author weblink DOI.
  • PUSEY CD. (1 Jan 1984). SPECIFIC IMMUNOABSORPTION IN AN EXPERIMENTAL-MODEL OF GOODPASTURE SYNDROME. ANNALES DE MEDECINE INTERNE. 135:37-37. Author weblink.
  • LANHAM JG; ELKON KB; PUSEY CD; HUGHES GR. (1 Jan 1984). SYSTEMIC VASCULITIS WITH ASTHMA AND EOSINOPHILIA - A CLINICAL APPROACH TO THE CHURG-STRAUSS-SYNDROME. MEDICINE. 63:65-81. Author weblink.
  • GURLAND HJ; DAU PC; LYSAGHT MJ; NOSE Y; PUSEY CD; SIAFACA K. (1 Jan 1983). CLINICAL PLASMAPHERESIS - WHO NEEDS IT. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS. 29:774-781. Author weblink.
  • EWAN PW; BARRETT HM; PUSEY CD. (1 Jan 1983). DEFECTIVE NATURAL KILLER(NK) AND KILLER(K) CELL-FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS. JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY. 10:71-76. Author weblink.
  • PUSEY CD; BOWMAN C; PETERS DK; LOCKWOOD CM. (1 Jan 1983). EFFECTS OF CYCLOPHOSPHAMIDE ON AUTOANTIBODY SYNTHESIS IN THE BROWN NORWAY RAT. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 54:697-704. Author weblink.
  • CAMILLERI M; PUSEY CD; CHADWICK VS; REES AJ. (1 Jan 1983). GASTROINTESTINAL MANIFESTATIONS OF SYSTEMIC VASCULITIS. QUARTERLY JOURNAL OF MEDICINE. 52:141-149. Author weblink.
  • SCHIFFERLI JA; AMOS N; PUSEY CD; SISSONS JGP; PETERS DK. (1 Jan 1983). METABOLISM OF IGG IN TYPE-II MIXED ESSENTIAL CRYOGLOBULINEMIA AUTOLOGOUS CRYOPRECIPITATED AND NORMAL HOMOLOGOUS IGG ARE INCORPORATED INTO COMPLEXES AND METABOLIZED INVIVO AT SIMILAR RATES. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 51:305-316. Author weblink.
  • PUSEY CD; LOCKWOOD CM; PETERS DK. (1 Jan 1983). PLASMA-EXCHANGE AND IMMUNOSUPPRESSIVE DRUGS IN THE TREATMENT OF GLOMERULONEPHRITIS DUE TO ANTIBODIES TO THE GLOMERULAR BASEMENT-MEMBRANE. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 6:15-18. Author weblink.
  • PUSEY CD. (1 Jan 1983). PLASMA-EXCHANGE IN GLOMERULONEPHRITIS RELATED TO IMMUNE-COMPLEX DEPOSITION. PLASMA THERAPY & TRANSFUSION TECHNOLOGY. 4:271-278. Author weblink.
  • PRESSEY A; PUSEY CD; DASH A; PETERS DK; LOCKWOOD CM. (1 Jan 1983). PRODUCTION OF A MONOCLONAL-ANTIBODY TO AUTOANTIGENIC COMPONENTS OF HUMAN GLOMERULAR BASEMENT-MEMBRANE. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 54:178-184. Author weblink.
  • CAMILLERI M; PUSEY CD; CHADWICK VS; REES AJ. (1 Jan 1982). GASTROINTESTINAL MANIFESTATIONS OF SYSTEMIC VASCULITIS. GUT. 23:A890-A890. Author weblink.
  • PUSEY CD. (1 Jan 1982). THE IMMUNOLOGY OF RENAL-DISEASE. PRACTITIONER. 226:2063-&. Author weblink.
  • PETERS DK; REES AJ; LOCKWOOD CM; PUSEY CD. (1 Jan 1982). TREATMENT AND PROGNOSIS IN ANTI-BASEMENT MEMBRANE ANTIBODY-MEDIATED NEPHRITIS. TRANSPLANTATION PROCEEDINGS. 14:513-521. Author weblink.

Books

  • Hewins P. Mason JC (ed); Pusey CD (ed). The Kidney in Systemic Autoimmune Diseases. 1, Handbook of Systemic Autoimmune Diseases:1-407. Elsevier, The Netherlands (2008).

Chapters in books

  • Allen AR; Pusey CD. Pulmonary renal syndrome. In Nephrology. 205-211. Davison AM (ed). McGraw Hill (2002).
  • Cook HT; Pusey CD. Pathology of vascular disease. 3-21. (2001).
  • Dorling A. Calcium, phosphate and magnesium disturbances. In Acute renal failure in practice. 174-183. (2002).
  • Gaskin G. Rapidly progressive glomerulonephritis. In Acute renal failure in practice. 341-355. (2002).
  • Gaskin G; Pusey CD. Vasculitis. 4th:792-804. (2001).
  • Griffin SV; Lockwood CM; Pusey CD. Plasmapheresis and immunoadsorption. 2nd:597-611. (2001).
  • Pusey CD. Goodpasture's syndrome and other anti-GBM disease. 3rd:172-175. (2001).
  • Salama AD; Pusey CD. Rheumatologic diseases associated with interstitial nephritis. 465-484. (2001).
  • Gaskin G; Pusey CD. Vasculitis. In Massry and Glassock's Textbook of Nephrology, 4th Edition. 792-804. Massry SG (ed); Glassock RJ (ed). Lippincott Williams and Wilkins, New York (2001).
  • Levy J; Pusey CD. Anti-glomerular basement membrane disease. In Oxford Textbook of Medicine, 4th Edition. 335-339. Warrell DA (ed); Cox TM (ed); Firth JD (ed). Oxford University Press, Oxford (2003).
  • Levy JB; Pusey CD. Crescentic glomerulonephritis. In Therapy in Nephrology and Hypertension, 2nd Edition. 177-188. Brady HR (ed); Wilcox CS (ed). WB Saunders, Philadelphia (2003).
  • Levy J; Pusey CD. Plasma exchange. In Comprehensive Clinical Nephrology, 2nd Edition. 1035-1042. Johnson RJ (ed); Feehally J (ed). Harcourt Publishers (2003).

Conferences

  • Pepper RJ; Tarzi R; Wang H-H; Pusey CD; Cook HT; Salama AD. Critical role for calprotectin in ANCA-AAV and GN. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:129-129. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • Arulkumaran N; Periselneris N; Gaskin G; Strickland N; Ind PW; Pusey CD; Salama AD. MPO-ANCA-AAV with pulmonary fibrosis. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:103-103. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • McAdoo S; Levy J; Hall A; Salama A; Pusey C. PR3-ANCA positivity in patients without primary ANCA-AAV. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:91-91. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • Morris H; Morgan MD; Woods A; Ekeowa UI; Butherus K; Holle JU; Guillevin L; Miranda E; et alLomas DA; Perez J; Pusey C; Salama A; Stockley R; Wieczorek S; Williams J; Savage CO; Harper L. ANCA-AAV, polymers and carriage of the Z allele of alpha 1AT. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:75-76. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • Pepper RJ; Chanouzas D; Tarzi R; Harper L; Pusey CD; Salama AD. Renal outcomes in patients presenting with dialysis-dependent ANCA-AAV treated with pulsed intravenous CyP. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:63-64. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • Harper L; Morgan MD; Flossman O; Westman K; de Groot K; Flores Suarez LF; Gregorini G; Gross WL; et alLuqmani R; Pusey CD; Rasmussen N; Sinico RA; Tesar V; Vanhille P; Berden A; Hagen C; Heijl C; Hoglund P; Mahr A; Mukhtyar C; Stegeman C; Walsh M; Savage CO; Jayne D. Pulse versus daily oral CyP for induction of remission in ANCA-associated vasculitis. A European, multi-centre randomized controlled trial: long-term follow-up. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:56-57. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • Arulkumaran N; West SC; Ind PW; Gaskin G; Tarzi R; Salama AD; Pusey CD. ANCA-AAV and PH. 15th International Vasculitis/ANCA Workshop, 15 May 2011 - 18 May 2011. 164:50-50. WILEY-BLACKWELL (1 May 2011). Author weblink.
  • Charif R; Marley S; Gordon M; Tait P; Apperley J; Davis J; Nicholls J; Pusey C; et alHabib N; Taube D; Papalois V. Phase I Clinical Study of Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34 Cells into Diabetic Patients with Renal Transplants. 10th American Transplant Congress, 1 May 2010 - 5 May 2010. 10:233-234. WILEY-BLACKWELL PUBLISHING, INC (1 Apr 2010).
  • de Jorge EG; Gale DP; Cook HT; Martinez-Barricarte R; Hadjisavvas A; Pusey CD; Palmer A; Fremeaux-Bacchi V; et alRodriguez de Cordoba S; Maxwell PH; Pickering MC. A mutant complement factor H-related 5 protein is associated with familial C3 glomerulonephritis. 12th European Meeting on Complement in Human Disease, 5 Sep 2009 - 8 Sep 2009. 46:2822-2822. PERGAMON-ELSEVIER SCIENCE LTD (1 Sep 2009). Author weblink DOI.
  • Reynolds J; Abbott DS; Karegli J; Evans DJ; Pusey CD. Mucosal Tolerance Induced by an Immunodominant Peptide from Rat alpha 3(IV)NC1 in Established Experimental Autoimmune Glomerulonephritis. 38th Annual Meeting of the American-Society-of-Nephrology/Annual Renal Week, 8 Nov 2005 - 13 Nov 2005. 174:2202-2210. AMER SOC INVESTIGATIVE PATHOLOGY, INC (1 Jun 2009). Author weblink DOI.
  • Buelli S; Abbate M; Morigi M; Moioli D; Zanchi C; Noris M; Zoja C; Pusey CD; et alZipfel PF; Remuzzi G. Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. 39th Annual Meeting of the American-Society-of-Nephrology/Annual Renal Week, 14 Nov 2006 - 19 Nov 2006. 75:1050-1059. NATURE PUBLISHING GROUP (1 May 2009). Author weblink DOI.
  • Reynolds J; Marshall D; Shaw S; Gelinas RE; Cook HT; Pusey CD. Effect of anti-IL6 monoclonal antibody therapy in experimental autoimmune glomerulonephritis in the CD1 mouse. Annual Congress of the British-Society-of-Immunology, 17 Nov 2008 - 21 Nov 2008. 125:60-60. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Reynolds J; Tadros S; Smith J; Cook PR; Bhangal G; Salama AD; Aitman TJ; Cook HT; et alPusey CD. Genetic susceptibility to experimental autoimmune glomerulonephritis in congenic rats. Annual Congress of the British-Society-of-Immunology, 17 Nov 2008 - 21 Nov 2008. 125:36-37. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • PUSEY CD. PLASMA-EXCHANGE IN IMMUNOLOGICAL DISEASE. 2ND INTERNATIONAL CONGRESS OF THE WORLD APHERESIS ASSOC, 18 May 1988 - 20 May 1988. 419-424. WILEY-LISS, INC (1 Jan 1990). Author weblink.
  • GASKIN G; CLUTTERBUCK EJ; PUSEY CD. RENAL-DISEASE IN THE CHURG-STRAUSS-SYNDROME - DIAGNOSIS, MANAGEMENT AND OUTCOME. 1ST SEMINAR ON RENAL INVOLVEMENT IN SYSTEMIC VASCULITIS, 22 Sep 1990. 94:58-65. KARGER (1 Jan 1991). Author weblink.
  • Prodromidi E; Poulsom R; Pusey C; Cook T. Bone marrow-derived stem cells contribute to regeneration and repair of the kidney. Joint Conference of the 33rd FEBS Congress/11th IUBMB Conference, 28 Jun 2008 - 3 Jul 2008. 275:462-462. BLACKWELL PUBLISHING (1 Jun 2008). Author weblink.
  • Nouraei SAR; Obholzer R; Ind PW; Salama AD; Pusey CD; Porter F; Howard DJ; Sandhu GS. Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis. 17th Annual Congress of the European-Respiratory-Society. 63:49-52. (Jan 2008).
  • PUSEY CD; GASKIN G. DISEASE ASSOCIATIONS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES. 4TH International Workshop on ANCA (Antineutrophil Cytoplasmic Antibodies) and 2nd International Colloquium on Wegeners Granulomatosis and Vasculitic Disorders. 336:145-155. (1993).
  • Booth AD; Bacon PA; Griffith ME; Harper L; Hammad T; Levy JB; Pusey CD; Savage CO; et alJayne DRW. Infliximab in ANCA-Associated vasculitis: The 'ACTIVE' trial. 36th Annual Meeting of the American-Society-of-Nephrology. 14:452A-452A. (Nov 2003).
  • Little MA; Smyth L; Buchatska O; Bhangal G; Wang S; Nourshargh S; Pusey CD. Comparison of the binding characteristics of ANCA from vasculitic patients with ANCA from a novel rat model of systemic vasculitis. 36th Annual Meeting of the American-Society-of-Nephrology. 14:414A-414A. (Nov 2003).
  • Khan SB; Bhangal G; Smith J; Cook S; Pusey CD. Blockade of TNF alpha is effective in the treatment of experimental crescentic glomerulonephritis. 36th Annual Meeting of the American-Society-of-Nephrology. 14:413A-414A. (Nov 2003).
  • Tarzi RM; Cook HT; Jackson I; Pusey CD; Lord GM. Leptin deficient mice are protected from nephrotoxic nephritis. 36th Annual Meeting of the American-Society-of-Nephrology. 14:175A-175A. (Nov 2003).
  • Barhamein MY; Tam FWK; Lai PC; Chaudhry A; Thompson M; Pusey CD; Lightstone L. Urinary monocyte chemoattractant protein-1 (uMCP-1) is more useful than PDGF-BB or IFN-gamma for monitoring activity of lupus nephritis (LN). 36th Annual Meeting of the American-Society-of-Nephrology. 14:148A-148A. (Nov 2003).
  • Prodromidi EI; Turnberg D; Roufosse CA; Jeffery R; Pusey CD; Poulsom R; Cook HT. Bone marrow-derived cells contribute to a small extent to regeneration of renal parenchyma after injury. 3rd Joint Meeting of the British Division of the International-Academy-of-Pahtology/Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. 207:2-2. (Oct 2005).
  • Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Hunt T; Pusey CD; Cook HT. Bone marrow contributes to podocyte regeneration and amelioration of renal disease in Alport's syndrome. 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. 210:60-60. (Sep 2006).
  • Reynolds J; Maine C; Sando GS; Salama AD; Pusey CD. Transfer of tolerance to naive recipients by CD4+ and CD25+ T cells from donors with experimental autoimmune glomerulonephritis treated with an anti-ICOSL monoclonal antibody. Annual Congress of the British-Society-of-Immunology. 120:35-35. (Mar 2007).
  • Reynolds J; Marsh OB; Sando GS; Salama AD; Pusey CD. Manipulation of the PD1/PDL1 negative T cell costimulatory pathway in treatment of established experimental autoimmune glomerulonephritis. Annual Congress of the British-Society-of-Immunology. 120:35-35. (Mar 2007).
  • Reynolds J; Karegli J; Abbott DA; Haxby J; Pusey CD. Nasal administration of an immunodominant peptide from rat alpha 3(IV)NC1 in the treatment of established experimental autoimmune glomerulonephritis. Annual Congress of the British-Society-of-Immunology, 20 Feb 2007 - 23 Feb 2007. 120:39-39. BLACKWELL PUBLISHING (1 Mar 2007). Author weblink.
  • Stangou M; Bhangal G; Lai P-C; Smith J; Keith J; Boyle J; Pusey C; Cook T; et alTam F. Interleukin-11 suppressed fibrotic processes in nephrotoxic nephritis in Wistar Kyoto Rats. 43rd ERA-EDTA Congress, 15 Jul 2006 - 18 Jul 2006. 21:36-37. OXFORD UNIV PRESS (1 Jul 2006). Author weblink.
  • GASKIN G; PUSEY C. IMMUNOLOGY OF SYSTEMIC VASCULITIS. 1ST INTERNATIONAL SYMP ON KIDNEY HEMAPHERESIS : CLINICAL IMMUNOLOGY AND TRANSPLANTS, 24 May 1991 - 25 May 1991. 143:57-62. MASSON EDITEUR (1 Jan 1992). Author weblink.
  • Patel A; Ind P; Pusey CD; Gaskin G; Salama A. Outcomes of pulmonary renal syndrome in patients with ANCA associated vasculitis. Winter Meeting of the British-Thoracic-Society, 2005. 60:II48-II48. B M J PUBLISHING GROUP (1 Dec 2005). Author weblink.
  • Reynolds J; Haxby J; Juggapah J; Pusey CD. Immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis. 36th Annual Meeting of the American-Society-of-Nephrology, 12 Nov 2003 - 17 Nov 2003. 14:633A-633A. LIPPINCOTT WILLIAMS & WILKINS (1 Nov 2003). Author weblink.
  • Pusey CD. T cell responses in ANCA-positive vasculitis. Antineutrophil Cytoplasmic Antibodies and Vasculitis Symposium at the XIV International Congress of Nephrology, 30 May 1997 - 1 Jun 1997. 3:S778-S779. BLACKWELL SCIENCE (1 Dec 1997). Author weblink DOI.
  • Levy JB; Coulthart A; George AJT; Pusey CD. The autoantibody response in Goodpasture's disease is highly restricted. 19th Annual General Meeting of the Association-of-Physicians-of-Great-Britain-and-Ireland, 11 Apr 1996 - 12 Apr 1996. 89:869-869. OXFORD UNIV PRESS UNITED KINGDOM (1 Nov 1996). Author weblink.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook